To Share or Not to Share Failed Genetic Screening Results with Patients


Aman Khera | Derek Ansel

If a patient does not screen positive for the targeted genetic variant when being screened for a study, is it advisable or is there any obligation for the study team to disclose the results to the patient? The answer isn’t a simple one. For best practices and considerations for including genetic testing in your clinical development strategy, read our article.

Your form has been successfully submitted! Click the button below to access.
READ MORE
Aman Khera
MEET THE AUTHOR

Aman Khera

Global Head of Regulatory Strategy
LEARN MORE
Derek Ansel
MEET THE AUTHOR

Derek Ansel

Executive Director, Therapeutic Strategy Lead, Rare Diseases
LEARN MORE